🔎 Trials Near Me

Home › Multiple Myeloma › New Jersey › Clifton

Pag-aaral pangklinika para sa Multiple Myeloma sa Clifton, NJ

14 pag-aaral para sa Multiple Myeloma ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Clifton (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma

Nagre-recruitPhase 1/2
  • Hackensack University Medical Center, Hackensack · 7 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT04973605

A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel

Nagre-recruitPhase 4
  • Hackensack University Medical Center, Hackensack · 7 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT05201781

Carfilzomib Based Chemotherapy Mobilization for Autologous Stem Cell Transplants in Multiple Myeloma

Nagre-recruitPhase 1
  • Hackensack Meridian Health - John Theurer Cancer Center, Hackensack · 7 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 21, 2026 · NCT03909412

A Study of Selinexor, in Combination With Carfilzomib, Daratumumab or Pomalidomide in Patients With Multiple Myeloma

Nagre-recruitPhase 2
  • John Theurer Cancer Center, Hackensack · 7 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 21, 2026 · NCT04661137

Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies

Nagre-recruitPhase 3
  • Hackensack Meridian Health, Hackensack · 7 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 21, 2026 · NCT07648264

A Study to Determine the Recommended Dose and Schedule, and Evaluate the Safety and Preliminary Efficacy of Mezigdomide in Combination With Elranatamab in Participants With Relapsed and/or Refractory Multiple Myeloma

Nagre-recruitPhase 1/2
  • Hackensack University Medical Center, Hackensack · 7 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 2, 2026 · NCT06988488

A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma

Nagre-recruitPhase 1
  • John Theurer Cancer Center, Hackensack University Medical Center, Hackensack · 7 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT07075185

A Modular, Phase I/II, Multicentre Study to Evaluate AZD4045, in Participants With Relapsed or Refractory Multiple Myeloma

Nagre-recruitPhase 1/2
  • Research Site, Hackensack · 7 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 27, 2026 · NCT07681596

A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma

Nagre-recruitPhase 1
  • Hackensack University Medical Center, Hackensack · 7 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 18, 2026 · NCT05651932

Mosaic Trial for Stem Cell Transplant Recipients

Nagre-recruit
  • Hackensack Meridian Health, Nutley · 3 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 3, 2026 · NCT06960993

A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma

Nagre-recruitPhase 1
  • John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 7 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 16, 2026 · NCT06121843

CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma

Nagre-recruitPhase 1
  • Hackensack Meridian John Theurer Cancer Center, Hackensack · 7 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2025 · NCT05722418

A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma

Nagre-recruitPhase 1/2
  • John Theurer Cancer Center at Hackensack UMC, Hackensack · 7 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 5, 2025 · NCT05372354

Pag-aaral para sa Multiple Myeloma sa ibang lungsod

Iba pang pag-aaral sa Clifton

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.